CRDL vs. ARKQ
CRDL (Cardiol Therapeutics Inc Class A) is a stock, while ARKQ (ARK Autonomous Technology & Robotics ETF) is Robotics fund actively managed by ARK. Over the past 5 years, CRDL returned -15.86%/yr vs 8.40%/yr for ARKQ. At a 0.30 correlation, their price movements are largely independent.
Performance
CRDL vs. ARKQ - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with CRDL having a 10.09% return and ARKQ slightly higher at 10.20%.
CRDL
- 1D
- -0.94%
- 1M
- -20.45%
- YTD
- 10.09%
- 6M
- 5.00%
- 1Y
- -17.97%
- 3Y*
- 8.09%
- 5Y*
- -15.86%
- 10Y*
- —
ARKQ
- 1D
- -2.83%
- 1M
- -7.26%
- YTD
- 10.20%
- 6M
- 5.80%
- 1Y
- 49.50%
- 3Y*
- 33.41%
- 5Y*
- 8.40%
- 10Y*
- 21.62%
CRDL vs. ARKQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
CRDL Cardiol Therapeutics Inc Class A | 10.09% | -25.48% | 51.80% | 65.33% | -72.43% | -15.14% | -38.35% | -5.49% |
ARKQ ARK Autonomous Technology & Robotics ETF | 10.20% | 48.81% | 33.88% | 40.70% | -46.75% | 1.74% | 107.20% | 20.19% |
Correlation
The correlation between CRDL and ARKQ is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.29 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Jan 15, 2019 | 0.30 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRDL vs. ARKQ — Risk / Return Rank
CRDL
ARKQ
CRDL vs. ARKQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cardiol Therapeutics Inc Class A (CRDL) and ARK Autonomous Technology & Robotics ETF (ARKQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRDL | ARKQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.73 | ||
| Sortino ratioReturn per unit of downside risk | -1.91 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.24 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | -0.45 | 2.42 | -2.87 |
| Martin ratioReturn relative to average drawdown | -0.64 | 6.99 | -7.63 |
Loading charts...
Drawdowns
CRDL vs. ARKQ - Drawdown Comparison
The maximum CRDL drawdown since its inception was -92.71%, which is greater than ARKQ's maximum drawdown of -59.89%. Use the drawdown chart below to compare losses from any high point for CRDL and ARKQ.
Loading charts...
Drawdown Indicators
| CRDL | ARKQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.71% | -59.89% | -32.82% |
Max Drawdown (1Y)Largest decline over 1 year | -39.87% | -20.58% | -19.29% |
Max Drawdown (3Y)Largest decline over 3 years | -72.73% | -30.76% | -41.97% |
Max Drawdown (5Y)Largest decline over 5 years | -90.72% | -55.71% | -35.01% |
Max Drawdown (10Y)Largest decline over 10 years | — | -59.89% | — |
Current DrawdownCurrent decline from peak | -83.04% | -12.14% | -70.90% |
Average DrawdownAverage peak-to-trough decline | -69.03% | -17.20% | -51.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.09% | 7.10% | +20.99% |
Volatility
CRDL vs. ARKQ - Volatility Comparison
The current volatility for Cardiol Therapeutics Inc Class A (CRDL) is 10.52%, while ARK Autonomous Technology & Robotics ETF (ARKQ) has a volatility of 12.96%. This indicates that CRDL experiences smaller price fluctuations and is considered to be less risky than ARKQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRDL | ARKQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.52% | 12.96% | -2.44% |
Volatility (6M)Calculated over the trailing 6-month period | 40.08% | 26.26% | +13.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.84% | 33.93% | +34.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.06% | 32.60% | +54.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.79% | 30.01% | +56.78% |
Dividends
CRDL vs. ARKQ - Dividend Comparison
CRDL has not paid dividends to shareholders, while ARKQ's dividend yield for the trailing twelve months is around 0.24%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKQ ARK Autonomous Technology & Robotics ETF | 0.24% | 0.27% | 0.00% | 0.00% | 0.00% | 0.80% | 0.86% | 0.00% | 2.86% | 1.54% | 0.00% | 0.98% |
CRDL Cardiol Therapeutics Inc Class A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CRDL and ARKQ have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKQ has higher volatility (12.96%) compared to CRDL (10.52%). In terms of maximum drawdown, CRDL dropped -92.71% vs ARKQ's -59.89%.
ARKQ currently has the higher Sharpe Ratio (1.47 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRDL and ARKQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer